IDEAS home Printed from https://ideas.repec.org/a/sae/medema/v42y2022i5p704-719.html
   My bibliography  Save this article

A Systematic Literature Review of Health Utility Values in Breast Cancer

Author

Listed:
  • Manraj N. Kaur

    (School of Rehabilitation Sciences, Faculty of Health Sciences, McMaster University, Hamilton, ON, Canada)

  • Jiajun Yan

    (Department of Health Research Methods, Evidence and Impact, Faculty of Health Sciences, McMaster University, Hamilton, ON, Canada)

  • Anne F. Klassen

    (Department of Pediatrics, Faculty of Health Sciences, McMaster University, Hamilton, ON, Canada)

  • Justin P. David

    (Faculty of Medicine, University of Toronto, Toronto, ON, Canada)

  • Dilshan Pieris

    (Faculty of Medicine, University of Toronto, Toronto, ON, Canada)

  • Manraj Sharma

    (Faculty of Medicine, University of Toronto, Toronto, ON, Canada)

  • Louise Bordeleau

    (Department of Oncology, Division of Medical Oncology, Faculty of Health Sciences, McMaster University, Hamilton, ON, Canada)

  • Feng Xie

    (Department of Health Research Methods, Evidence and Impact, Faculty of Health Sciences, McMaster University, Hamilton, ON, Canada)

Abstract

Background Health utility values (HUVs) are important inputs to the cost-utility analysis of breast cancer interventions. Purpose Provide a catalog of breast cancer–related published HUVs across different stages of breast cancer and treatment interventions. Data Sources Systematic searches of MEDLINE, MEDLINE In-Process, EMBASE, Web of Science, CINAHL, PsycINFO, EconLit, and Cochrane databases (2005–2017). Study Selection Studies published in English that reported mean or median HUVs using direct or indirect methods of utility elicitation for breast cancer. Data Extraction Independent reviewers extracted data on a preestablished and piloted form; disagreements were resolved through discussion. Data Analysis Mixed-effects meta-regression using restricted maximum likelihood modeling was conducted for intervention type, stage of breast cancer, and typical clinical and treatment trajectory of breast cancer patients to assess the effect of study characteristics (i.e., sample size, utility elicitation method, and respondent type) on HUVs. Data Synthesis Seventy-nine studies were included in the review. Most articles ( n = 52, 66%) derived HUVs using the EQ-5D. Patients with advanced-stage breast cancer (range, 0.08 to 0.82) reported lower HUVs as compared with patients with early-stage breast cancer (range, 0.58 to 0.99). The meta-regression analysis found that undergoing chemotherapy and surgery and radiation, being diagnosed with an advanced stage of breast cancer, and recurrent cancer were associated with lower HUVs. The members of the general public reported lower HUVs as compared with patients. Limitations There was considerable heterogeneity in the study population, health states assessed, and utility elicitation methods. Conclusion This review provides a catalog of published HUVs related to breast cancer. The substantial heterogeneity in the health utility studies makes it challenging for researchers to choose which HUVs to use in cost-utility analyses for breast cancer interventions.

Suggested Citation

  • Manraj N. Kaur & Jiajun Yan & Anne F. Klassen & Justin P. David & Dilshan Pieris & Manraj Sharma & Louise Bordeleau & Feng Xie, 2022. "A Systematic Literature Review of Health Utility Values in Breast Cancer," Medical Decision Making, , vol. 42(5), pages 704-719, July.
    • Handle: RePEc:sae:medema:v:42:y:2022:i:5:p:704-719
    DOI: 10.1177/0272989X211065471
    as

    Download full text from publisher

    File URL: https://journals.sagepub.com/doi/10.1177/0272989X211065471
    Download Restriction: no
    File URL: https://libkey.io/10.1177/0272989X211065471?utm_source=ideas
    LibKey link: if access is restricted and if your library uses this service, LibKey will redirect you to where you can use your library subscription to access this item
    ---><---

    Citations

    Citations are extracted by the CitEc Project, subscribe to its RSS feed for this item.
    as


    Cited by:

    1. Maria Richert & Marek Dudek, 2023. "Risk Mapping: Ranking and Analysis of Selected, Key Risk in Supply Chains," JRFM, MDPI, vol. 16(2), pages 1-30, January.

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:sae:medema:v:42:y:2022:i:5:p:704-719. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    We have no bibliographic references for this item. You can help adding them by using this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: SAGE Publications (email available below). General contact details of provider: .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.